Startseite>>Signaling Pathways>> Microbiology & Virology>> HCV>>Hepatitis C virus

Hepatitis C virus (Synonyms: H2N-Leu-Leu-Ala-Leu-Leu-Ser-Cys-Leu-Thr-Val-OH )

Katalog-Nr.GP10026

Hepatitis C virus, (C48H88N10O13S), a peptide with the sequence H2N-Leu-Leu-Ala-Leu-Leu-Ser-Cys-Leu-Thr-Val-OH, MW= 1045.34.

Products are for research use only. Not for human use. We do not sell to patients.

Hepatitis C virus Chemische Struktur

Größe Preis Lagerbestand Menge
1mg
5,00 $
Auf Lager
5mg
15,00 $
Auf Lager
10mg
25,00 $
Auf Lager
25mg
35,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Hepatitis C virus, (C48H88N10O13S), a peptide with the sequence H2N-Leu-Leu-Ala-Leu-Leu-Ser-Cys-Leu-Thr-Val-OH, MW= 1045.34. Hepatitis C virus (HCV or sometimes HVC) is a small (55–65 nm in size), enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. Hepatitis C virus is the cause of hepatitis C in humans. The study of HCV has been hampered by the narrow host range of HCV. The use of replicons has been successful but these have only been recently discovered. HCV, as with most RNA viruses, exists as a viral quasispecies, making it very difficult to isolate a single strain or receptor type for study. HCV is spread primarily by blood-to-blood contact associated with intravenous drug use, poorly sterilized medical equipment and transfusions. An estimated 130–200 million people worldwide are infected with hepatitis C(1). Hepatitis C only infects humans and chimpanzees(2).The virus persists in the liver in about 85% of those infected. This persistent infection can be treated with medication: the standard therapy is a combination of peginterferon and ribavirin, with either boceprevir or telaprevir added in some cases. Overall, 50–80% of people treated are cured. Those who develop cirrhosis or liver cancer may require a liver transplant. Hepatitis C is the leading cause of liver transplantation, though the virus usually recurs after transplantation(3). No vaccine against hepatitis C is available.

A1045_1

Figurethe structures of Hepatitis C virus

A1145_2

Figure 2  mechanisms of HCV interference with the immune system

Ref:

1. Gravitz L. (2011). "A smouldering public-health crisis". Nature 474 (7350): S2-4.

2. Shors, Teri (2011-11-08). Understanding viruses (2nd ed.).Burlington,MA: Jones & Bartlett Learning. pp. 535.

3. Rosen, HR (2011-06-23). "Clinical practice. Chronic hepatitis C infection". The New England Journal of Medicine 364 (25): 2429–38.  

Bewertungen

Review for Hepatitis C virus

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Hepatitis C virus

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.